0001567619-22-021733.txt : 20221216 0001567619-22-021733.hdr.sgml : 20221216 20221216170050 ACCESSION NUMBER: 0001567619-22-021733 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221216 DATE AS OF CHANGE: 20221216 EFFECTIVENESS DATE: 20221216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eterna Therapeutics Inc. CENTRAL INDEX KEY: 0000748592 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 311103425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-467803 FILM NUMBER: 221468692 BUSINESS ADDRESS: STREET 1: 10355 SCIENCE CENTER DRIVE STREET 2: SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (212) 582-1199 MAIL ADDRESS: STREET 1: 10355 SCIENCE CENTER DRIVE STREET 2: SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc. DATE OF NAME CHANGE: 20210325 FORMER COMPANY: FORMER CONFORMED NAME: NTN BUZZTIME INC DATE OF NAME CHANGE: 20051230 FORMER COMPANY: FORMER CONFORMED NAME: NTN COMMUNICATIONS INC DATE OF NAME CHANGE: 19920703 D 1 primary_doc.xml X0708 D LIVE 0000748592 Eterna Therapeutics Inc. 10355 Science Center Drive Suite 150 San Diego CA CALIFORNIA 92121 (212) 582-1199 DELAWARE NTN Buzztime, Inc. Brooklyn ImmunoTherapeutics, Inc. NTN BUZZTIME INC NTN COMMUNICATIONS INC Corporation true Matthew Angel Eterna Therapeutics, Inc. 10355 Science Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director Executive Officer Interim President and Chief Executive Officer Andrew Jackson Eterna Therapeutics, Inc. 10355 Science Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Executive Officer Chief Financial Officer Roger Sidhu Eterna Therapeutics, Inc. 10355 Science Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Executive Officer Chief Medical Officer Sandra Gurrola Eterna Therapeutics, Inc. 10355 Science Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Executive Officer Vice President, Finance Charles Cherington Eterna Therapeutics, Inc. 10355 Science Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director Gregory Fiore Eterna Therapeutics, Inc. 10355 Science Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director William Wexler Eterna Therapeutics, Inc. 10355 Science Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director Nicholas J. Singer Eterna Therapeutics, Inc. 10355 Science Center Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2022-12-02 false true true Units consisting of (i) one share of common stock and (ii) two warrants to purchase one share common stock ("common warrants") false 0 7712874 7712874 0 false 20 0 0 0 false Eterna Therapeutics Inc. /s/ Andrew Jackson Andrew Jackson Chief Financial Officer 2022-12-13